Canary

Canary is the most influential early-stage firm in Brazilian venture, and its healthcare investing reflects the broader ambition to build the operating system for Latin American technology rather than to specialize in any single vertical. The firm writes $1M-$5M checks across pre-seed, seed, and Series A out of Sao Paulo and treats digital health and AI in healthcare as part of a wider thesis about software reshaping the largest sectors of the regional economy. Founders pitching Canary should expect a regionally grounded conversation rather than a US-style vertical specialist diligence.

The declared sub-verticals are digital health and AI/ML in healthcare. In practice the firm has been most active in care delivery technology, telehealth, healthcare IT for the underbuilt Latin American provider and payer infrastructure, and AI-enabled consumer and clinical applications. The thesis benefits from the structural reality that Latin American healthcare systems run on weaker software and looser data infrastructure than US peers, which creates greenfield opportunities that look quaint to Bay Area investors but are real and large for founders building on the ground.

Check sizes of $1M-$5M position Canary as a lead or co-lead on most early-stage rounds in the region, often anchoring the cap table that subsequent international investors join. Geographically the focus is Brazil and broader Latin America, with deep relationships across regional founders, follow-on funds, and the cross-border investors who eventually move into Latin American Series B and C rounds. The firm has cultivated relationships with global funds that want regional exposure but rely on Canary to do the early-stage work and govern the company through the formative years.

The team is built around investors and operators who have spent careers in Latin American technology and finance. Diligence tends to be founder-centric and relationship-oriented, with sharp attention to the realities of building in regulated, sometimes turbulent local markets. Founders should expect engagement that is more hands-on than typical seed-stage venture, particularly on the practical questions of hiring, financial structuring, and navigating regulatory shifts that vary across Latin American countries.

For founders, the practical read is that Canary is the natural early lead for Latin American digital health and healthcare AI companies, particularly those scaling from Brazil into the broader region. It is less useful for US-only companies or for founders who want a generalist tech investor without regional context. The engagement style is concentrated and supportive, with real time spent on operational and strategic questions. Founders building healthcare technology in Latin America and looking for a firm that can lead the seed round and stay through Series A while pulling in international syndicates over time will find Canary the most credible regional option for that role.